FDA Inspection 921927 — Antoine Vonk Noordegraaf
The FDA completed an inspection of Antoine Vonk Noordegraaf on April 17, 2015 in Amsterdam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 17, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amsterdam (Netherlands)
Additional Details
Clinical Investigator (CI)